09

Robert Arnold, a palliative-care expert at the University of Pittsburgh, will discuss what clinicians can do when conflicts crop up over what constitutes appropriate care.

Making cell- or virus-based therapies for use in humans requires a rigid set of quality-control standards outlined by the Food and Drug Administration. A new Stanford facility will allow promising new therapies to be tested in the clinic.

Inhibiting the firing of nerve cells in a brain area long known to guide goal-directed behavior makes mice build nests and fall asleep, a new study shows. Stimulating the circuit roused the mice and kept them awake.

Stanford's class of 93 first-year medical students meet their cadavers for the first time, a rite of passage on the journey to becoming physicians.

The study is designed to collect neurophysiological and psychological information from women faced with a breast cancer diagnosis and many treatment decisions.